As part of the ODIN project’s activities, particularly the whole-genome sequencing (WGS) component for pathogens of interest, a training course was held in Nanoro from 1 to 5 June 2026. ...
Dans le cadre des activités du projet ODIN, notamment sur le volet de séquençage du génome entier (WGS) des pathogènes d’intérêt, une formation s’est tenue à Nanoro du 1er ...
Garantir l'accès à l'eau potable reste un défi majeur de santé publique dans de nombreuses régions d'Afrique subsaharienne. Le lot de travail 5 (WP5) du projet ODIN contribue à rendre ...
Ensuring access to safe drinking water remains a major public health challenge in many parts of sub Saharan Africa. The ODIN project WP5 is contributing to safer and more resilient ...
Nous avons le plaisir d’annoncer une nouvelle publication du consortium ODIN dans BMC Infectious Diseases, intitulée « Exploiter la génomique et la bio-informatique pour la surveillance des agents pathogènes en Afrique : revue exploratoire des formations existantes et des lacunes en matière de formation ». Cette revue offre une vue d’ensemble complète des initiatives de formation en génomique et en bio-informatique soutenant la surveillance ...
This CfP comprises two workstreams: i) Epidemiology, modelling and analytics; and ii) Immunological and clinical assessment of potential cross-reactive antibodies induced by investigational or licensed vaccines against Zaïre and Sudan Ebola virus. Applications must be submitted under one selected workstream. Read more
CEPI has launched a call for proposals to fund preclinical and/or Phase 1 proof-of-concept studies for promising Bundibugyo virus vaccine candidates. Prospective applicants are invited to watch the webinar which addressed questions about the call and application process. Read more
CEPI is seeking technical partners to enable rapid, ethical, and coordinated access to high-quality biospecimens during outbreaks and public health emergencies. Organisations of all sizes and capability levels are encouraged to apply, particularly those located in low- and middle-income countries. Read more
Proposed projects will be expected to increase regulatory and research ethics oversight capacity of national and regional authorities in SSA to operate at WHO maturity level 3 for clinical trial, registration and/or PV for medical products (therapeutics/vaccines) Read more
The BSI will help facilitate the timely and ethical collection of biological samples in an outbreak. The BSI aims to make biospecimens available to develop assays and standards within weeks, rather than the six months it typically takes today. Read more
CEPI has published its first Biosecurity Policy, strengthening safe, responsible, and equitable research. The Policy outlines clear biosecurity and biosafety requirements for Third Parties, supporting our mission to advance global health preparedness and protect communities through secure scientific innovation. Read more
Resources
In collaboration with TGHN, CEPI created this playbook to bring together the many tools, resources and materials generated for pandemic preparedness and response from the COVID-19 pandemic. The first (Regulatory) chapter is now available.
TRANSVAC Academy offers training modules in vaccine R&D including grant management, statistics, cytometry and advanced process development. CEPI funded scholarships are provided to selected applicants from LMICs.
SPEAC is a CEPI and Brighton Collaboration project. SPEAC provides vaccine safety tools, resources, and expertise throughout the vaccine development process to enhance safety and build confidence in vaccines.
Monitoring Vaccine Performance against SARS CoV-2 Variants
The IVAC COVID-19 Vaccine Effectiveness Project (a CEPI- funded global systematic review which also includes neutralization capacity) outputs are publicly available on VIEWhub to assist all policy makers
International Pandemic Preparedness Secretariat
The IPPS serves to join up relevant states, the private sector, and global health institutions in support of the 100 Days Mission, across vaccines, therapeutics, and diagnostics. It performs a global annual progress review related to the 100 DM which feeds into implementation reports.
Vaccine Development
Process Maps
The UK Vaccine R&D Network has developed vaccine development maps to show key stages in human and veterinary vaccines development up to Phase III clinical trials. These process maps and associated case studies provide support in understanding key stages in vaccine development and where bottlenecks could cause delays.
